Promising Parkinson's drug decoded

Promising Parkinson's drug decoded

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed of and recycled. This includes the mitochondria, the powerhouses of our cells. Impaired quality control of mitochondria plays a central role in Parkinson's disease.

The study revealed sensory deficiencies in magnetic resonance signals in response to incentives in the olfative and visual pathways that were attributed to neural origins and vascular contributions.

How basic research paves the way for new therapies – from genetic shears to RNA vaccines

Parkinson Cell Therapy ANPD001 Generates Promising Early-Stage Phase 1/2 Data

Early findings from the ASPIRO trial showed ANPD001 was safe, well-tolerated, and led to marked improvements in motor symptoms and daily functioning.

Early Parkinson's detection with an RNA-based blood test

The test has the potential to alleviate the uncertainty faced by patients and clinicians, offering a reliable and rapid method to identify Parkinson's disease in its earliest stages.